00:00
Well, let’s start with dilated cardiomyopathy,
one of the most common. It starts with dilatation
of the cardiac chambers, usually the left
ventricle to start with and this is an attempt
at compensating for damage to the heart muscle
in the left ventricle. Remember Starling’s
law, the rubber band law of the heart? There’s
an attempt here, as the heart dilates, to
actually improve its squeeze and improve the
stroke volume and cardiac output. It’s quite
common. There’s approximately 10,000 deaths
a year in the United States from this. This
is quite a small number compared to ischemic
heart disease, but nevertheless, these patients
are quite sick and so, they are often repeatedly
in the hospital. Again, the underlying pathophysiology
is abnormal heart function. When little chunks
of heart muscle are taken, for example, when
these patients undergo heart transplantation
and they’re put into a little experimental
muscle bath, you can see that they contract
very weakly as compared to a normal heart
muscle.
01:10
When I was in training, it was thought that
a genetic form of dilated cardiomyopathy was
quite rare. However, now that we have DNA
analysis and there’s been a great deal of
research done in this area, it turns out that,
in fact, 1/3 of patients have a genetic abnormality
as the cause of their dilated cardiomyopathy
and in the future, it may be even a higher
percentage. What happens with these DNA abnormalities
is that a piece of the protein that is involved
in the contracting mechanism of the little
heart cells is actually abnormal. There’s
an abnormality in the motor, if you will,
which is transmitted genetically by the DNA.
01:53
Here’s a little diagram which shows you
on the left-hand side, the normal heart. You
can see the normal thickness of the left ventricle,
normal thickness of the right ventricle, normal
cavity size. Look at the right-hand diagram.
You can see that the right and left ventricle
are both quite dilated, and the left ventricle
is particularly thin-walled. The right ventricle
isn’t much thin-walled, but it is quite
dilated. And of course, this is what happens
in the process of the development of this
cardiomyopathy. First, the left ventricle
begins to fail. It dilates up. That results
in increased pressures in the lung, and that
results in increased work of the right ventricle,
and eventually, then the right ventricle dilates
and fails. It’s a common question to medical
students - What’s the commonest cause of
right ventricular failure? And the answer
is, of course, left ventricular failure because
the two are connected and related in the same
system.
02:53
Here is a little more colorful diagram showing
you the same thing. On the left-hand side,
we see the normal heart - normal left ventricular
cavity, normal thickness. On the… Below
it, the right ventricle, and here, on the
other side, you see the dilated cardiomyopathy
- dilated left ventricle, dilated right ventricle.
You can also see how when the ventricle dilates,
the ring that contains both the mitral valve
and the ring that contains the tricuspid valve
could be stretched leading to secondary mitral
and tricuspid regurgitation. Remember, we
talked about that in the valvular heart disease
section, that a common cause of mitral and
tricuspid leaks were dilatation of the ventricle
when they stretch the annulus that is the
ring in which the valve sits, little fibrous
ring in which the valve sits so that the valve
leaflets can’t come quite together, and
consequently, there’s regurgitation. Sometimes
when the patients are treated successfully
and the ventricles shrink down a bit, so-called
functional mitral and tricuspid regurgitation
can get better.
04:01
Now, let’s talk a little bit about statistics.
Again, dilated cardiomyopathy, not that common,
5 to 8 per 100,000. Coronary disease, much
much more common. But, nevertheless, it is
a very serious condition when it develops.
In previous times, 50% of these patients would
be dead within 5 years. These days, about
75% survive 5 years. Still, that’s a very
high mortality rate. Indeed, many cancers
are not quite as bad as that. And we think
of heart failure particularly related to cardiomyopathy
as a very malignant disease within cardiology.